Home / Eletriptan / Canada
CA ATC N02CC06 · updated 2 Nov 2026
Eletriptan shortage in Canada
Is there an Eletriptan shortage in Canada?
Yes. As of 2 Nov 2026, 2 Eletriptan products are reported short in Canada, the first since 21 May 2026. The company estimate for the return is 8 Dec 2026 (latest 29 Dec 2026). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Sweden, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | RELPAX (1x6 BLS) | BGP PHARMA ULC | 21 May 2026 | 8 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-ELETRIPTAN (1x6 BLS) | MYLAN PHARMACEUTICALS ULC | 1 Jun 2026 | 29 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.